As the nationwide death toll related to the meningitis outbreak grew to 20 patients, 24 NH medical practices have been asked by the state’s Department of Health and Human Services to contact patients who may have been exposed to a growing list of injectable drugs manufactured by New England Compounding Center in Framingham.
As investigation of the meningitis outbreak intensifies, the list of pharmaceutical products under scrutiny has also expanded.
According to one media source, “This is an expanded list of products from the initially recalled steroid – three lots of methylprednisolone acetate used for injections for pain management – used at only two New Hampshire clinics – Pain Care in Merrimack and Somersworth – who gave the steroid as an epidural injection. The Newington Pain Care location was added to the list a couple days later when it was learned that the steroid may have been injected into joints, as well.
The new list includes any injectable NECC product, as well as any ophthalmic drug that is used in conjunction with eye surgery and a cardioplegic solution – a solution that can be used in certain cardiac surgeries. DPHS has posted online the names of the 24 New Hampshire healthcare providers who received these products.”
1-800-662-6230 or email@example.com
Latest posts by Kevin Dugan (see all)
- Unsolicited Patient Observations Help Identify Surgeons More Likely to Commit Malpractice - August 1, 2018
- Lead Extractions in Catherization Labs May Result in Wrongful Death - February 19, 2018
- Sidestepping the Repeal of Joint and Several Liability a Case Study - March 18, 2017